Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2007
03/13/2007US7189545 Enzymatic polypeptide associated with synthesis of phenylacetylcarbinol for use as intermediate in preparation of ephedrine
03/13/2007US7189540 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proteins
03/13/2007US7189539 Polypeptides, fragments and homologues; vectors, host cells, antibodies; genetic engineering and expression; treatment of urogenital, sexual, metabolic, inflammatory, pregnancy, and g-protein coupled receptor disorders; drug screening
03/13/2007US7189535 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
03/13/2007US7189534 PRO4320 polynucleotide
03/13/2007US7189533 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2007US7189532 PRO polypeptides; fusion proteins
03/13/2007US7189529 PRO792 nucleic acids
03/13/2007US7189521 Claudin polypeptides, polynucleotides, and methods of making and use thereof
03/13/2007US7189519 Identifying bound modified g-protein coupled receptors assemblies; microarrays; drug screening; colorimetric analysis
03/13/2007US7189514 Cotton event PV-GHGT07(1445) and compositions and methods for detection thereof
03/13/2007US7189511 Retina-specific detection of age-related macular degeneration; drug sceening
03/13/2007US7189510 Response element compositions and assays employing same
03/13/2007US7189508 Using microarrays, fluorescently labeled oligonucleotide probes and polymerase chain reaction to identify and measure nucleotide sequence concentrations
03/13/2007US7189506 DNA binding compound-mediated molecular switch system
03/13/2007US7189404 Strain selection of pneumococcal surface proteins
03/13/2007CA2240494C Therapeutic molecules generated by trans-splicing
03/13/2007CA2170604C Nucleic acid purification compositions and methods
03/13/2007CA2099482C Anther-specific cdna sequences, genomic dna sequences and recombinant dna sequences
03/08/2007WO2007028121A2 Eg8798 and eg9703 polynucleotides and uses thereof
03/08/2007WO2007026929A1 Method for separating and purifying rna
03/08/2007WO2007026824A1 Oligonucleotide analogs
03/08/2007WO2007026485A1 Universal base
03/08/2007WO2007025365A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms
03/08/2007WO2006124686A3 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness
03/08/2007WO2006122049A3 Pna probes for detecting mollicutes
03/08/2007WO2006110760A3 Compositions and methods for the diagnosis and treatment of tumor
03/08/2007WO2006110347A3 Single walled carbon nanotubes functionally adsorbed to biopolymers for use as chemical sensors
03/08/2007WO2006099055A3 Sequence, polymorphisms, and marker test technology for disease resistance and growth (nfkb1)
03/08/2007WO2006097320A3 Macromolecular nucleotide links and methods for their use
03/08/2007WO2006076691A3 Irta-2 antibodies and their uses
03/08/2007WO2006038212A3 Methods and compositions for the diagnosis and treatment of cancer
03/08/2007WO2005051174A3 Nucleic acid aptamer-based compositions and methods
03/08/2007WO2004093524A3 Oxygen-resistant hydrogenases and methods for designing and making same
03/08/2007WO2004016760A3 Novel variant hyprocrea jecorina cbh1 cellulases
03/08/2007WO2003094835A3 Fgf variants and methods for use thereof
03/08/2007US20070056060 Transforming a plant cell with a nucleic acid sequence that encodes the acquired resistance polypeptide, regenerating a plant from the transformed plant cell; resistance to fungal pathogens
03/08/2007US20070056058 Dominant negative mutant krp protein protection of active cyclin-cdk complex inhibition by wild-type krp
03/08/2007US20070056057 Methods and means for obtaining modified phenotypes
03/08/2007US20070056055 Facilitates the development of transgenic plants in which tissue preferred expression, constitutive expression, and the strength of transgene expression is either more or less critical; directs tissue-specific or tissue-preferential, or constitutive, transcription of a linked nucleic acid segment
03/08/2007US20070056053 Glucosidases, nucleic acids encoding them and methods for making and using them
03/08/2007US20070055453 Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
03/08/2007US20070055056 251 human secreted proteins
03/08/2007US20070055050 Methods and reagents for diagnosis and treatment of diabetes
03/08/2007US20070055048 Process for supported phase synthesis
03/08/2007US20070054872 Regulatable or conditional expression systems
03/08/2007US20070054869 Antisense modulation of superoxide dismutase 1, soluble expression
03/08/2007US20070054845 Which block binding of polypeptides; treatment of metabolic disorders such as obesity, hyperlipidemias, atherosclerosis, diabetes, and hypertension
03/08/2007US20070054385 Using transgenic yarrowia as biorector for production of omega-3 or omega-6 fatty acids
03/08/2007US20070054383 Genes encoding carbon metabolism and energy-producing proteins
03/08/2007US20070054382 DNA, nucleaotides sequences and polynucleotides that code for sugar metabolism and oxidative phosphorylation proteins; genetic engineered microorganisms used for biosynthesis of amino acids
03/08/2007US20070054381 Genes encoding genetic stability, gene expression and folding proteins
03/08/2007US20070054380 L-lysine-producing corynebacteria and process for the preparation of l-lysine
03/08/2007US20070054379 Nucleotide sequences which encode the pfk gene
03/08/2007US20070054377 Homogeneous preparations of il-28 and il-29
03/08/2007US20070054376 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing
03/08/2007US20070054375 Mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity
03/08/2007US20070054374 Homogeneous preparations of il-28 and il-29
03/08/2007US20070054366 Fvii or fviia variants
03/08/2007US20070054365 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
03/08/2007US20070054364 Polypeptide variants
03/08/2007US20070054362 Recombinant production of mixtures of antibodies
03/08/2007US20070054360 Compositions and methods for modulating immune responses
03/08/2007US20070054358 Insertion sequence-free bacteria
03/08/2007US20070054356 Glycine-rich proteins, their coding genes and applications
03/08/2007US20070054355 Cbl-b polypeptides, complexes and related methods
03/08/2007US20070054354 E.coli host cells with modified phos/psts periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs
03/08/2007US20070054353 Nuclear receptor transcriptional corepressor and uses thereof
03/08/2007US20070054336 Compounds and methods for diagnosis and immunotherapy of tuberculosis
03/08/2007US20070054315 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for producing the complex structure
03/08/2007US20070054314 Adiponectin receptor and gene encoding the same
03/08/2007US20070054312 Human transmembrane proteins
03/08/2007US20070054310 Novel polypeptide, cDNA encoding the same, and use thereof
03/08/2007US20070054303 Expression Vectors and Methods
03/08/2007US20070054297 combining drugs with human orphan leucine-repeat-containing, G protein-coupled receptors (LGR7) polypeptides, then evaluating the level of binding to the hromones or the level of cAMP production; drug screening and design
03/08/2007US20070054294 Cotton event PV-GHGT07(1445) and compositions and methods for detection thereof
03/08/2007US20070054290 Bind to hedgehog polypeptides with high affinity; exhibit spatially and temporally restricted expression domains indicative of important roles in hedgehog-mediated induction
03/08/2007US20070054286 Arrays of nucleic acid probes for analyzing biotransformation genes
03/08/2007US20070054285 Method for isolating nucleic acids
03/08/2007US20070054279 Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
03/08/2007US20070054278 Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
03/08/2007US20070054277 Computer-directed assembly of a polynucleotide encoding a target polypeptide
03/08/2007US20070054272 Method of preparing dna fragments by selective fragmentation of nucleic acids and applications thereof
03/08/2007US20070054267 Primer and probe for detecting vibrio vulnificus and detection method using the same
03/08/2007US20070054263 PCR based assays; restriction fragment length polymorphism; gel electrophoresis; kits
03/08/2007US20070053991 Cartilage-derived morphogenetic proteins
03/08/2007US20070053936 Expression vector comprising nucleotide sequences coding microorganismal polypeptide for use in generating agents for prevention and treatment of infection
03/08/2007US20070053935 Nucleotide sequences coding HEV (hemorrhagic enteritis virus) or EDS (egg drop syndrome virus) capsid proteins for use in vaccinating domestic birds against pathogenic adenoviral infection
03/08/2007US20070053927 Chlamydia pneumoniae polynucleotides and uses thereof
03/08/2007US20070053926 Antigenic neisserial peptides
03/08/2007US20070053924 Conserved and specific streptococcal genomes
03/08/2007US20070053922 Epitope based vaccines directed towards HPV; side effect reduction; vaccination
03/08/2007US20070053916 Plasmodium falciparum peptide for use in stimulating immune response to treat and prevent malaria
03/08/2007US20070053915 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
03/08/2007US20070053912 Compounds for neutralizing the effects of secreted pla2iia
03/08/2007US20070053903 Methods of using pHHLA2 to co-stimulate T-cells
03/08/2007US20070053902 Anti-alphabeta3 humanized monoclonal antibodies
03/08/2007US20070053890 Canine embryonic stem cells
03/08/2007US20070053880 Growth differentiation factor-16
03/08/2007US20070053879 Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator
1 ... 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 ... 899